BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Press Releases

  InflaRx to Showcase Vilobelimab’s Role in Immuno-Dermatology at the 2025 AAD Annual Meeting

  February 28, 2025

   · 

  7 min read
• Press Releases

  Novartis data presentations at AAAAI and AAD underscore commitment to advancing treatment of hidradenitis suppurativa (HS) and chronic spontaneous urticaria (CSU)

  February 28, 2025

   · 

  7 min read
• Press Releases

  Arrowhead Pharmaceuticals Launches on Rare Disease Day New Patient-Centric Resources for Those Affected by Familial Chylomicronemia Syndrome (FCS)

  February 28, 2025

   · 

  7 min read
• 

  Layoffs

  Eisai Will Trim About 7% of US Workforce, Including New Jersey Employees

  Eisai’s cuts will affect 121 employees across the Japanese company’s U.S. operations, including 57 people at its American headquarters in Nutley, New Jersey. A company spokesperson said the pharma remains fully committed to the U.S. market.

  February 28, 2025

   · 

  1 min read

   · 

  Angela Gabriel
• 

  Editorial

  Transparency Missing in Action at HHS Despite Leaders’ Calls for Clarity

  In the five weeks since Donald Trump returned as U.S. president, the FDA, NIH and CDC have been thrown into disarray, with meetings regarding vaccines and rare diseases canceled or indefinitely postponed—all without a clear reason why.

  February 28, 2025

   · 

  4 min read

   · 

  Heather McKenzie
• Press Releases

  Incyte to Unveil New Data from its Dermatology Portfolio at 2025 American Academy of Dermatology (AAD) Annual Meeting

  February 28, 2025

   · 

  6 min read
• Press Releases

  Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine

  February 28, 2025

   · 

  4 min read
• Press Releases

  Lilly to participate in Leerink Partners Global Healthcare Conference

  February 28, 2025

   · 

  2 min read
• Press Releases

  Bambusa Therapeutics Announces First Subject Dosed in Phase 1 Clinical Trial of BBT001, a Novel Multi-Targeting, Half-Life Extended Bispecific Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Skin Diseases

  February 28, 2025

   · 

  3 min read
• Press Releases

  BioMark Diagnostics Underscores Commitment to Rare Disease Research on Rare Disease Day 2025

  BioMark is pioneering liquid biopsy solutions for challenging conditions and championing equity in diagnosis

  February 28, 2025

   · 

  3 min read